nodes	percent_of_prediction	percent_of_DWPC	metapath
Fomepizole—CYP2A6—Tamoxifen—pancreatic cancer	0.177	0.31	CbGbCtD
Fomepizole—CYP2E1—Dacarbazine—pancreatic cancer	0.147	0.257	CbGbCtD
Fomepizole—CYP2A6—Fluorouracil—pancreatic cancer	0.13	0.228	CbGbCtD
Fomepizole—CYP2E1—Tamoxifen—pancreatic cancer	0.117	0.205	CbGbCtD
Fomepizole—Transaminitis—Gemcitabine—pancreatic cancer	0.0389	0.154	CcSEcCtD
Fomepizole—Phlebosclerosis—Epirubicin—pancreatic cancer	0.0186	0.0738	CcSEcCtD
Fomepizole—Phlebosclerosis—Doxorubicin—pancreatic cancer	0.0172	0.0683	CcSEcCtD
Fomepizole—ADH1B—gall bladder—pancreatic cancer	0.0129	0.188	CbGeAlD
Fomepizole—ADH1C—islet of Langerhans—pancreatic cancer	0.012	0.175	CbGeAlD
Fomepizole—Lymphangitis—Epirubicin—pancreatic cancer	0.00945	0.0375	CcSEcCtD
Fomepizole—CAT—islet of Langerhans—pancreatic cancer	0.00939	0.137	CbGeAlD
Fomepizole—Lymphangitis—Doxorubicin—pancreatic cancer	0.00874	0.0347	CcSEcCtD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—DAXX—pancreatic cancer	0.00859	0.079	CbGpPWpGaD
Fomepizole—ADH1C—pancreas—pancreatic cancer	0.00841	0.123	CbGeAlD
Fomepizole—ADH1A—digestive system—pancreatic cancer	0.00733	0.107	CbGeAlD
Fomepizole—CAT—Oxidative Stress—NFE2L2—pancreatic cancer	0.00731	0.0672	CbGpPWpGaD
Fomepizole—CAT—pancreas—pancreatic cancer	0.0066	0.0963	CbGeAlD
Fomepizole—Disseminated intravascular coagulation—Sunitinib—pancreatic cancer	0.00649	0.0258	CcSEcCtD
Fomepizole—CAT—digestive system—pancreatic cancer	0.00564	0.0823	CbGeAlD
Fomepizole—ADH1B—digestive system—pancreatic cancer	0.00508	0.0741	CbGeAlD
Fomepizole—CAT—Detoxification of Reactive Oxygen Species—SOD2—pancreatic cancer	0.00442	0.0407	CbGpPWpGaD
Fomepizole—CAT—Nucleotide metabolism—TYMP—pancreatic cancer	0.00422	0.0388	CbGpPWpGaD
Fomepizole—CAT—Oxidative Stress—SOD2—pancreatic cancer	0.00407	0.0374	CbGpPWpGaD
Fomepizole—Application site reaction—Fluorouracil—pancreatic cancer	0.0039	0.0155	CcSEcCtD
Fomepizole—CAT—FoxO family signaling—GADD45A—pancreatic cancer	0.00376	0.0345	CbGpPWpGaD
Fomepizole—Disseminated intravascular coagulation—Docetaxel—pancreatic cancer	0.0037	0.0147	CcSEcCtD
Fomepizole—CAT—Nucleotide metabolism—DPYD—pancreatic cancer	0.00335	0.0308	CbGpPWpGaD
Fomepizole—Transaminases increased—Gemcitabine—pancreatic cancer	0.00306	0.0121	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00299	0.0275	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—BCL2L1—pancreatic cancer	0.00284	0.0261	CbGpPWpGaD
Fomepizole—CAT—FoxO family signaling—SOD2—pancreatic cancer	0.00275	0.0252	CbGpPWpGaD
Fomepizole—Injection site inflammation—Epirubicin—pancreatic cancer	0.00267	0.0106	CcSEcCtD
Fomepizole—Heartburn—Fluorouracil—pancreatic cancer	0.00266	0.0105	CcSEcCtD
Fomepizole—Nystagmus—Fluorouracil—pancreatic cancer	0.00256	0.0102	CcSEcCtD
Fomepizole—Anuria—Epirubicin—pancreatic cancer	0.00255	0.0101	CcSEcCtD
Fomepizole—Injection site inflammation—Doxorubicin—pancreatic cancer	0.00247	0.00979	CcSEcCtD
Fomepizole—Lightheadedness—Tamoxifen—pancreatic cancer	0.00242	0.00961	CcSEcCtD
Fomepizole—Anuria—Doxorubicin—pancreatic cancer	0.00236	0.00936	CcSEcCtD
Fomepizole—CAT—Folate Metabolism—SOD2—pancreatic cancer	0.00216	0.0199	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFE2L2—pancreatic cancer	0.00216	0.0198	CbGpPWpGaD
Fomepizole—Visual disturbance—Tamoxifen—pancreatic cancer	0.00207	0.00823	CcSEcCtD
Fomepizole—Heartburn—Docetaxel—pancreatic cancer	0.00192	0.00761	CcSEcCtD
Fomepizole—Hiccups—Irinotecan—pancreatic cancer	0.00191	0.00758	CcSEcCtD
Fomepizole—CAT—Nucleotide metabolism—TYMS—pancreatic cancer	0.00191	0.0175	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—CASP3—pancreatic cancer	0.00175	0.0161	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.00172	0.0158	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.0015	0.0138	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—SMAD4—pancreatic cancer	0.00149	0.0137	CbGpPWpGaD
Fomepizole—Transaminases increased—Epirubicin—pancreatic cancer	0.00146	0.00581	CcSEcCtD
Fomepizole—Visual disturbance—Irinotecan—pancreatic cancer	0.00146	0.0058	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—SOD2—pancreatic cancer	0.00145	0.0133	CbGpPWpGaD
Fomepizole—CAT—FoxO family signaling—CTNNB1—pancreatic cancer	0.00138	0.0127	CbGpPWpGaD
Fomepizole—Transaminases increased—Doxorubicin—pancreatic cancer	0.00135	0.00537	CcSEcCtD
Fomepizole—Pharyngitis—Tamoxifen—pancreatic cancer	0.00135	0.00535	CcSEcCtD
Fomepizole—CYP2A6—NRF2 pathway—FGF13—pancreatic cancer	0.00131	0.0121	CbGpPWpGaD
Fomepizole—Visual impairment—Tamoxifen—pancreatic cancer	0.00131	0.0052	CcSEcCtD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TNF—pancreatic cancer	0.00128	0.0117	CbGpPWpGaD
Fomepizole—Flushing—Tamoxifen—pancreatic cancer	0.00126	0.00501	CcSEcCtD
Fomepizole—Nystagmus—Epirubicin—pancreatic cancer	0.00125	0.00495	CcSEcCtD
Fomepizole—CYP2E1—digestive system—pancreatic cancer	0.00121	0.0177	CbGeAlD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PLAU—pancreatic cancer	0.0012	0.0111	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.00119	0.0109	CbGpPWpGaD
Fomepizole—Bradycardia—Sunitinib—pancreatic cancer	0.00119	0.0047	CcSEcCtD
Fomepizole—Lightheadedness—Docetaxel—pancreatic cancer	0.00118	0.00469	CcSEcCtD
Fomepizole—Dysgeusia—Tamoxifen—pancreatic cancer	0.00116	0.0046	CcSEcCtD
Fomepizole—Nystagmus—Doxorubicin—pancreatic cancer	0.00115	0.00458	CcSEcCtD
Fomepizole—Back pain—Tamoxifen—pancreatic cancer	0.00115	0.00454	CcSEcCtD
Fomepizole—Eosinophilia—Fluorouracil—pancreatic cancer	0.00114	0.00451	CcSEcCtD
Fomepizole—Back pain—Erlotinib—pancreatic cancer	0.00113	0.00449	CcSEcCtD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TP53—pancreatic cancer	0.00112	0.0103	CbGpPWpGaD
Fomepizole—Phlebitis—Docetaxel—pancreatic cancer	0.00111	0.00441	CcSEcCtD
Fomepizole—Anaemia—Tamoxifen—pancreatic cancer	0.00109	0.00434	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—HSPA1B—pancreatic cancer	0.00109	0.01	CbGpPWpGaD
Fomepizole—Flushing—Sunitinib—pancreatic cancer	0.00108	0.00429	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PIK3CG—pancreatic cancer	0.00107	0.00985	CbGpPWpGaD
Fomepizole—Visual disturbance—Docetaxel—pancreatic cancer	0.00101	0.00401	CcSEcCtD
Fomepizole—Anxiety—Tamoxifen—pancreatic cancer	0.001	0.00398	CcSEcCtD
Fomepizole—Anxiety—Erlotinib—pancreatic cancer	0.000994	0.00394	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—EZH2—pancreatic cancer	0.000993	0.00914	CbGpPWpGaD
Fomepizole—Dysgeusia—Sunitinib—pancreatic cancer	0.000993	0.00394	CcSEcCtD
Fomepizole—Back pain—Sunitinib—pancreatic cancer	0.000981	0.00389	CcSEcCtD
Fomepizole—Bradycardia—Irinotecan—pancreatic cancer	0.000977	0.00387	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000965	0.00888	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PIK3CD—pancreatic cancer	0.000942	0.00866	CbGpPWpGaD
Fomepizole—Shock—Erlotinib—pancreatic cancer	0.000941	0.00373	CcSEcCtD
Fomepizole—Anaemia—Sunitinib—pancreatic cancer	0.000937	0.00372	CcSEcCtD
Fomepizole—Pharyngitis—Gemcitabine—pancreatic cancer	0.000928	0.00368	CcSEcCtD
Fomepizole—Visual impairment—Irinotecan—pancreatic cancer	0.000925	0.00367	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—HSPA1A—pancreatic cancer	0.000921	0.00847	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—pancreatic cancer	0.000916	0.00843	CbGpPWpGaD
Fomepizole—Pharyngitis—Fluorouracil—pancreatic cancer	0.000912	0.00362	CcSEcCtD
Fomepizole—Hiccups—Epirubicin—pancreatic cancer	0.000891	0.00353	CcSEcCtD
Fomepizole—Flushing—Irinotecan—pancreatic cancer	0.000891	0.00353	CcSEcCtD
Fomepizole—Convulsion—Sunitinib—pancreatic cancer	0.000879	0.00348	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CDKN2A—pancreatic cancer	0.00087	0.008	CbGpPWpGaD
Fomepizole—Dyspepsia—Tamoxifen—pancreatic cancer	0.000851	0.00337	CcSEcCtD
Fomepizole—Dyspepsia—Erlotinib—pancreatic cancer	0.000842	0.00334	CcSEcCtD
Fomepizole—Decreased appetite—Tamoxifen—pancreatic cancer	0.00084	0.00333	CcSEcCtD
Fomepizole—Decreased appetite—Erlotinib—pancreatic cancer	0.000831	0.0033	CcSEcCtD
Fomepizole—Pain—Tamoxifen—pancreatic cancer	0.000826	0.00328	CcSEcCtD
Fomepizole—Hiccups—Doxorubicin—pancreatic cancer	0.000824	0.00327	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PIK3CB—pancreatic cancer	0.000821	0.00755	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—TNF—pancreatic cancer	0.00082	0.00754	CbGpPWpGaD
Fomepizole—Pain—Erlotinib—pancreatic cancer	0.000818	0.00324	CcSEcCtD
Fomepizole—Shock—Sunitinib—pancreatic cancer	0.000814	0.00323	CcSEcCtD
Fomepizole—Back pain—Irinotecan—pancreatic cancer	0.000808	0.0032	CcSEcCtD
Fomepizole—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00079	0.00313	CcSEcCtD
Fomepizole—Back pain—Gemcitabine—pancreatic cancer	0.000787	0.00312	CcSEcCtD
Fomepizole—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000782	0.0031	CcSEcCtD
Fomepizole—CAT—FoxO family signaling—AKT1—pancreatic cancer	0.000775	0.00713	CbGpPWpGaD
Fomepizole—Anaemia—Irinotecan—pancreatic cancer	0.000772	0.00306	CcSEcCtD
Fomepizole—Abdominal pain—Tamoxifen—pancreatic cancer	0.000764	0.00303	CcSEcCtD
Fomepizole—Body temperature increased—Erlotinib—pancreatic cancer	0.000756	0.003	CcSEcCtD
Fomepizole—Abdominal pain—Erlotinib—pancreatic cancer	0.000756	0.003	CcSEcCtD
Fomepizole—Vision blurred—Fluorouracil—pancreatic cancer	0.000754	0.00299	CcSEcCtD
Fomepizole—Anaemia—Gemcitabine—pancreatic cancer	0.000752	0.00298	CcSEcCtD
Fomepizole—Phlebitis—Epirubicin—pancreatic cancer	0.000751	0.00298	CcSEcCtD
Fomepizole—Vertigo—Irinotecan—pancreatic cancer	0.00075	0.00298	CcSEcCtD
Fomepizole—Anaemia—Fluorouracil—pancreatic cancer	0.000739	0.00293	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CCND1—pancreatic cancer	0.000735	0.00676	CbGpPWpGaD
Fomepizole—Dyspepsia—Sunitinib—pancreatic cancer	0.000728	0.00289	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CTNNB1—pancreatic cancer	0.000728	0.00669	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—TP53—pancreatic cancer	0.000723	0.00665	CbGpPWpGaD
Fomepizole—Decreased appetite—Sunitinib—pancreatic cancer	0.000719	0.00285	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—SOD2—pancreatic cancer	0.000714	0.00656	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PTEN—pancreatic cancer	0.000709	0.00652	CbGpPWpGaD
Fomepizole—Pain—Sunitinib—pancreatic cancer	0.000708	0.00281	CcSEcCtD
Fomepizole—Phlebitis—Doxorubicin—pancreatic cancer	0.000695	0.00275	CcSEcCtD
Fomepizole—Convulsion—Fluorouracil—pancreatic cancer	0.000693	0.00275	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000678	0.00623	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000677	0.00268	CcSEcCtD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—pancreatic cancer	0.000674	0.0062	CbGpPWpGaD
Fomepizole—Shock—Irinotecan—pancreatic cancer	0.000671	0.00266	CcSEcCtD
Fomepizole—Diarrhoea—Tamoxifen—pancreatic cancer	0.000661	0.00262	CcSEcCtD
Fomepizole—Pharyngitis—Docetaxel—pancreatic cancer	0.000658	0.00261	CcSEcCtD
Fomepizole—Abdominal pain—Sunitinib—pancreatic cancer	0.000654	0.00259	CcSEcCtD
Fomepizole—Body temperature increased—Sunitinib—pancreatic cancer	0.000654	0.00259	CcSEcCtD
Fomepizole—Diarrhoea—Erlotinib—pancreatic cancer	0.000654	0.00259	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—TNF—pancreatic cancer	0.000652	0.00599	CbGpPWpGaD
Fomepizole—Visual impairment—Docetaxel—pancreatic cancer	0.000639	0.00254	CcSEcCtD
Fomepizole—Dizziness—Tamoxifen—pancreatic cancer	0.000639	0.00253	CcSEcCtD
Fomepizole—Tachycardia—Fluorouracil—pancreatic cancer	0.000637	0.00253	CcSEcCtD
Fomepizole—Hypotension—Irinotecan—pancreatic cancer	0.000637	0.00253	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—NRAS—pancreatic cancer	0.000633	0.00582	CbGpPWpGaD
Fomepizole—Dizziness—Erlotinib—pancreatic cancer	0.000632	0.00251	CcSEcCtD
Fomepizole—Hypotension—Gemcitabine—pancreatic cancer	0.00062	0.00246	CcSEcCtD
Fomepizole—Flushing—Docetaxel—pancreatic cancer	0.000616	0.00244	CcSEcCtD
Fomepizole—Vomiting—Tamoxifen—pancreatic cancer	0.000614	0.00244	CcSEcCtD
Fomepizole—Hypotension—Fluorouracil—pancreatic cancer	0.00061	0.00242	CcSEcCtD
Fomepizole—Rash—Tamoxifen—pancreatic cancer	0.000609	0.00242	CcSEcCtD
Fomepizole—Dermatitis—Tamoxifen—pancreatic cancer	0.000609	0.00241	CcSEcCtD
Fomepizole—Vomiting—Erlotinib—pancreatic cancer	0.000608	0.00241	CcSEcCtD
Fomepizole—Somnolence—Irinotecan—pancreatic cancer	0.000606	0.0024	CcSEcCtD
Fomepizole—Headache—Tamoxifen—pancreatic cancer	0.000605	0.0024	CcSEcCtD
Fomepizole—Rash—Erlotinib—pancreatic cancer	0.000603	0.00239	CcSEcCtD
Fomepizole—Dermatitis—Erlotinib—pancreatic cancer	0.000602	0.00239	CcSEcCtD
Fomepizole—Dyspepsia—Irinotecan—pancreatic cancer	0.0006	0.00238	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—HIF1A—pancreatic cancer	0.000599	0.00551	CbGpPWpGaD
Fomepizole—Headache—Erlotinib—pancreatic cancer	0.000599	0.00238	CcSEcCtD
Fomepizole—Decreased appetite—Irinotecan—pancreatic cancer	0.000593	0.00235	CcSEcCtD
Fomepizole—Somnolence—Gemcitabine—pancreatic cancer	0.00059	0.00234	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—MYC—pancreatic cancer	0.000589	0.00542	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TGFB1—pancreatic cancer	0.000588	0.00541	CbGpPWpGaD
Fomepizole—Pain—Irinotecan—pancreatic cancer	0.000583	0.00231	CcSEcCtD
Fomepizole—Somnolence—Fluorouracil—pancreatic cancer	0.00058	0.0023	CcSEcCtD
Fomepizole—Decreased appetite—Gemcitabine—pancreatic cancer	0.000577	0.00229	CcSEcCtD
Fomepizole—Dyspepsia—Fluorouracil—pancreatic cancer	0.000575	0.00228	CcSEcCtD
Fomepizole—Nausea—Tamoxifen—pancreatic cancer	0.000574	0.00228	CcSEcCtD
Fomepizole—Pain—Gemcitabine—pancreatic cancer	0.000568	0.00225	CcSEcCtD
Fomepizole—Nausea—Erlotinib—pancreatic cancer	0.000568	0.00225	CcSEcCtD
Fomepizole—Decreased appetite—Fluorouracil—pancreatic cancer	0.000568	0.00225	CcSEcCtD
Fomepizole—Diarrhoea—Sunitinib—pancreatic cancer	0.000566	0.00225	CcSEcCtD
Fomepizole—Dysgeusia—Docetaxel—pancreatic cancer	0.000565	0.00224	CcSEcCtD
Fomepizole—ADH1B—Metabolism—PRSS1—pancreatic cancer	0.000562	0.00517	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PRSS1—pancreatic cancer	0.000562	0.00517	CbGpPWpGaD
Fomepizole—Back pain—Docetaxel—pancreatic cancer	0.000559	0.00222	CcSEcCtD
Fomepizole—Pain—Fluorouracil—pancreatic cancer	0.000558	0.00221	CcSEcCtD
Fomepizole—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000557	0.00221	CcSEcCtD
Fomepizole—Eosinophilia—Epirubicin—pancreatic cancer	0.000553	0.00219	CcSEcCtD
Fomepizole—Dizziness—Sunitinib—pancreatic cancer	0.000547	0.00217	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—KRAS—pancreatic cancer	0.000545	0.00501	CbGpPWpGaD
Fomepizole—Abdominal pain—Irinotecan—pancreatic cancer	0.000539	0.00214	CcSEcCtD
Fomepizole—Body temperature increased—Irinotecan—pancreatic cancer	0.000539	0.00214	CcSEcCtD
Fomepizole—Anaemia—Docetaxel—pancreatic cancer	0.000534	0.00212	CcSEcCtD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—pancreatic cancer	0.000531	0.00488	CbGpPWpGaD
Fomepizole—Vomiting—Sunitinib—pancreatic cancer	0.000526	0.00209	CcSEcCtD
Fomepizole—Body temperature increased—Gemcitabine—pancreatic cancer	0.000525	0.00208	CcSEcCtD
Fomepizole—Rash—Sunitinib—pancreatic cancer	0.000522	0.00207	CcSEcCtD
Fomepizole—Dermatitis—Sunitinib—pancreatic cancer	0.000521	0.00207	CcSEcCtD
Fomepizole—Headache—Sunitinib—pancreatic cancer	0.000518	0.00206	CcSEcCtD
Fomepizole—Body temperature increased—Fluorouracil—pancreatic cancer	0.000516	0.00205	CcSEcCtD
Fomepizole—Eosinophilia—Doxorubicin—pancreatic cancer	0.000512	0.00203	CcSEcCtD
Fomepizole—CAT—Metabolism—PRSS1—pancreatic cancer	0.000506	0.00465	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PIK3CA—pancreatic cancer	0.0005	0.0046	CbGpPWpGaD
Fomepizole—Convulsion—Docetaxel—pancreatic cancer	0.0005	0.00198	CcSEcCtD
Fomepizole—Drowsiness—Epirubicin—pancreatic cancer	0.000498	0.00198	CcSEcCtD
Fomepizole—Nausea—Sunitinib—pancreatic cancer	0.000492	0.00195	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—RB1—pancreatic cancer	0.000488	0.00448	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ARG2—pancreatic cancer	0.000487	0.00448	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ARG2—pancreatic cancer	0.000487	0.00448	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TP53—pancreatic cancer	0.000484	0.00445	CbGpPWpGaD
Fomepizole—Diarrhoea—Irinotecan—pancreatic cancer	0.000466	0.00185	CcSEcCtD
Fomepizole—ADH1A—Metabolism—PRSS1—pancreatic cancer	0.000466	0.00428	CbGpPWpGaD
Fomepizole—Shock—Docetaxel—pancreatic cancer	0.000464	0.00184	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—HRAS—pancreatic cancer	0.000463	0.00426	CbGpPWpGaD
Fomepizole—Drowsiness—Doxorubicin—pancreatic cancer	0.000461	0.00183	CcSEcCtD
Fomepizole—Tachycardia—Docetaxel—pancreatic cancer	0.00046	0.00182	CcSEcCtD
Fomepizole—Bradycardia—Epirubicin—pancreatic cancer	0.000455	0.00181	CcSEcCtD
Fomepizole—Diarrhoea—Gemcitabine—pancreatic cancer	0.000454	0.0018	CcSEcCtD
Fomepizole—Dizziness—Irinotecan—pancreatic cancer	0.000451	0.00179	CcSEcCtD
Fomepizole—Diarrhoea—Fluorouracil—pancreatic cancer	0.000447	0.00177	CcSEcCtD
Fomepizole—Pharyngitis—Epirubicin—pancreatic cancer	0.000444	0.00176	CcSEcCtD
Fomepizole—Hypotension—Docetaxel—pancreatic cancer	0.00044	0.00175	CcSEcCtD
Fomepizole—CAT—Metabolism—ARG2—pancreatic cancer	0.000439	0.00403	CbGpPWpGaD
Fomepizole—Vomiting—Irinotecan—pancreatic cancer	0.000433	0.00172	CcSEcCtD
Fomepizole—Dizziness—Fluorouracil—pancreatic cancer	0.000432	0.00171	CcSEcCtD
Fomepizole—Visual impairment—Epirubicin—pancreatic cancer	0.000431	0.00171	CcSEcCtD
Fomepizole—Rash—Irinotecan—pancreatic cancer	0.00043	0.0017	CcSEcCtD
Fomepizole—Dermatitis—Irinotecan—pancreatic cancer	0.000429	0.0017	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CDKN2A—pancreatic cancer	0.000429	0.00394	CbGpPWpGaD
Fomepizole—Headache—Irinotecan—pancreatic cancer	0.000427	0.00169	CcSEcCtD
Fomepizole—ADH1B—Metabolism—TYMP—pancreatic cancer	0.000426	0.00392	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—TYMP—pancreatic cancer	0.000426	0.00392	CbGpPWpGaD
Fomepizole—Vomiting—Gemcitabine—pancreatic cancer	0.000422	0.00167	CcSEcCtD
Fomepizole—Bradycardia—Doxorubicin—pancreatic cancer	0.000421	0.00167	CcSEcCtD
Fomepizole—Somnolence—Docetaxel—pancreatic cancer	0.000419	0.00166	CcSEcCtD
Fomepizole—Rash—Gemcitabine—pancreatic cancer	0.000419	0.00166	CcSEcCtD
Fomepizole—Dermatitis—Gemcitabine—pancreatic cancer	0.000418	0.00166	CcSEcCtD
Fomepizole—Headache—Gemcitabine—pancreatic cancer	0.000416	0.00165	CcSEcCtD
Fomepizole—Flushing—Epirubicin—pancreatic cancer	0.000415	0.00165	CcSEcCtD
Fomepizole—Vomiting—Fluorouracil—pancreatic cancer	0.000415	0.00165	CcSEcCtD
Fomepizole—Dyspepsia—Docetaxel—pancreatic cancer	0.000415	0.00165	CcSEcCtD
Fomepizole—Rash—Fluorouracil—pancreatic cancer	0.000412	0.00163	CcSEcCtD
Fomepizole—Dermatitis—Fluorouracil—pancreatic cancer	0.000411	0.00163	CcSEcCtD
Fomepizole—Pharyngitis—Doxorubicin—pancreatic cancer	0.000411	0.00163	CcSEcCtD
Fomepizole—Decreased appetite—Docetaxel—pancreatic cancer	0.00041	0.00162	CcSEcCtD
Fomepizole—Headache—Fluorouracil—pancreatic cancer	0.000409	0.00162	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—AKT1—pancreatic cancer	0.000409	0.00376	CbGpPWpGaD
Fomepizole—Nausea—Irinotecan—pancreatic cancer	0.000405	0.00161	CcSEcCtD
Fomepizole—ADH1A—Metabolism—ARG2—pancreatic cancer	0.000404	0.00371	CbGpPWpGaD
Fomepizole—Pain—Docetaxel—pancreatic cancer	0.000403	0.0016	CcSEcCtD
Fomepizole—Visual impairment—Doxorubicin—pancreatic cancer	0.000399	0.00158	CcSEcCtD
Fomepizole—Nausea—Gemcitabine—pancreatic cancer	0.000394	0.00156	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CXCL8—pancreatic cancer	0.000389	0.00357	CbGpPWpGaD
Fomepizole—Nausea—Fluorouracil—pancreatic cancer	0.000388	0.00154	CcSEcCtD
Fomepizole—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000385	0.00153	CcSEcCtD
Fomepizole—Flushing—Doxorubicin—pancreatic cancer	0.000384	0.00152	CcSEcCtD
Fomepizole—CAT—Metabolism—TYMP—pancreatic cancer	0.000384	0.00353	CbGpPWpGaD
Fomepizole—Dysgeusia—Epirubicin—pancreatic cancer	0.000381	0.00151	CcSEcCtD
Fomepizole—Back pain—Epirubicin—pancreatic cancer	0.000377	0.00149	CcSEcCtD
Fomepizole—Body temperature increased—Docetaxel—pancreatic cancer	0.000373	0.00148	CcSEcCtD
Fomepizole—Abdominal pain—Docetaxel—pancreatic cancer	0.000373	0.00148	CcSEcCtD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00037	0.00341	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—NFE2L2—pancreatic cancer	0.000368	0.00338	CbGpPWpGaD
Fomepizole—Vision blurred—Epirubicin—pancreatic cancer	0.000367	0.00146	CcSEcCtD
Fomepizole—Anaemia—Epirubicin—pancreatic cancer	0.00036	0.00143	CcSEcCtD
Fomepizole—Agitation—Epirubicin—pancreatic cancer	0.000358	0.00142	CcSEcCtD
Fomepizole—ADH1A—Metabolism—TYMP—pancreatic cancer	0.000353	0.00325	CbGpPWpGaD
Fomepizole—Dysgeusia—Doxorubicin—pancreatic cancer	0.000353	0.0014	CcSEcCtD
Fomepizole—CYP2A6—NRF2 pathway—TGFA—pancreatic cancer	0.000351	0.00323	CbGpPWpGaD
Fomepizole—Vertigo—Epirubicin—pancreatic cancer	0.00035	0.00139	CcSEcCtD
Fomepizole—Back pain—Doxorubicin—pancreatic cancer	0.000349	0.00138	CcSEcCtD
Fomepizole—CYP2A6—NRF2 pathway—SLC2A2—pancreatic cancer	0.000343	0.00316	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GLP1R—pancreatic cancer	0.000343	0.00316	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GLP1R—pancreatic cancer	0.000343	0.00316	CbGpPWpGaD
Fomepizole—Vision blurred—Doxorubicin—pancreatic cancer	0.00034	0.00135	CcSEcCtD
Fomepizole—ADH1B—Metabolism—DPYD—pancreatic cancer	0.000338	0.00311	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—DPYD—pancreatic cancer	0.000338	0.00311	CbGpPWpGaD
Fomepizole—Convulsion—Epirubicin—pancreatic cancer	0.000337	0.00134	CcSEcCtD
Fomepizole—Anaemia—Doxorubicin—pancreatic cancer	0.000333	0.00132	CcSEcCtD
Fomepizole—Agitation—Doxorubicin—pancreatic cancer	0.000331	0.00131	CcSEcCtD
Fomepizole—Anxiety—Epirubicin—pancreatic cancer	0.00033	0.00131	CcSEcCtD
Fomepizole—Vertigo—Doxorubicin—pancreatic cancer	0.000324	0.00128	CcSEcCtD
Fomepizole—Diarrhoea—Docetaxel—pancreatic cancer	0.000322	0.00128	CcSEcCtD
Fomepizole—ADH1B—Metabolism—SLC2A2—pancreatic cancer	0.000321	0.00295	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—SLC2A2—pancreatic cancer	0.000321	0.00295	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—VEGFA—pancreatic cancer	0.000316	0.0029	CbGpPWpGaD
Fomepizole—Shock—Epirubicin—pancreatic cancer	0.000313	0.00124	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—STAT3—pancreatic cancer	0.000313	0.00287	CbGpPWpGaD
Fomepizole—Convulsion—Doxorubicin—pancreatic cancer	0.000312	0.00124	CcSEcCtD
Fomepizole—Dizziness—Docetaxel—pancreatic cancer	0.000312	0.00124	CcSEcCtD
Fomepizole—Tachycardia—Epirubicin—pancreatic cancer	0.00031	0.00123	CcSEcCtD
Fomepizole—CAT—Metabolism—GLP1R—pancreatic cancer	0.000309	0.00284	CbGpPWpGaD
Fomepizole—Anxiety—Doxorubicin—pancreatic cancer	0.000306	0.00121	CcSEcCtD
Fomepizole—CAT—Metabolism—DPYD—pancreatic cancer	0.000304	0.0028	CbGpPWpGaD
Fomepizole—Vomiting—Docetaxel—pancreatic cancer	0.0003	0.00119	CcSEcCtD
Fomepizole—Rash—Docetaxel—pancreatic cancer	0.000297	0.00118	CcSEcCtD
Fomepizole—Hypotension—Epirubicin—pancreatic cancer	0.000297	0.00118	CcSEcCtD
Fomepizole—Dermatitis—Docetaxel—pancreatic cancer	0.000297	0.00118	CcSEcCtD
Fomepizole—Headache—Docetaxel—pancreatic cancer	0.000295	0.00117	CcSEcCtD
Fomepizole—Shock—Doxorubicin—pancreatic cancer	0.000289	0.00115	CcSEcCtD
Fomepizole—CAT—Metabolism—SLC2A2—pancreatic cancer	0.000289	0.00265	CbGpPWpGaD
Fomepizole—Tachycardia—Doxorubicin—pancreatic cancer	0.000287	0.00114	CcSEcCtD
Fomepizole—ADH1A—Metabolism—GLP1R—pancreatic cancer	0.000284	0.00262	CbGpPWpGaD
Fomepizole—Somnolence—Epirubicin—pancreatic cancer	0.000283	0.00112	CcSEcCtD
Fomepizole—Nausea—Docetaxel—pancreatic cancer	0.00028	0.00111	CcSEcCtD
Fomepizole—ADH1A—Metabolism—DPYD—pancreatic cancer	0.00028	0.00257	CbGpPWpGaD
Fomepizole—Dyspepsia—Epirubicin—pancreatic cancer	0.00028	0.00111	CcSEcCtD
Fomepizole—Decreased appetite—Epirubicin—pancreatic cancer	0.000276	0.0011	CcSEcCtD
Fomepizole—Hypotension—Doxorubicin—pancreatic cancer	0.000275	0.00109	CcSEcCtD
Fomepizole—Pain—Epirubicin—pancreatic cancer	0.000272	0.00108	CcSEcCtD
Fomepizole—ADH1A—Metabolism—SLC2A2—pancreatic cancer	0.000266	0.00244	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—HSPA1A—pancreatic cancer	0.000264	0.00243	CbGpPWpGaD
Fomepizole—Somnolence—Doxorubicin—pancreatic cancer	0.000261	0.00104	CcSEcCtD
Fomepizole—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00026	0.00103	CcSEcCtD
Fomepizole—Dyspepsia—Doxorubicin—pancreatic cancer	0.000259	0.00103	CcSEcCtD
Fomepizole—Decreased appetite—Doxorubicin—pancreatic cancer	0.000256	0.00101	CcSEcCtD
Fomepizole—Pain—Doxorubicin—pancreatic cancer	0.000251	0.000997	CcSEcCtD
Fomepizole—Body temperature increased—Epirubicin—pancreatic cancer	0.000251	0.000997	CcSEcCtD
Fomepizole—Abdominal pain—Epirubicin—pancreatic cancer	0.000251	0.000997	CcSEcCtD
Fomepizole—ADH1C—Metabolism—CD44—pancreatic cancer	0.000248	0.00228	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CD44—pancreatic cancer	0.000248	0.00228	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00024	0.000954	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—TP53—pancreatic cancer	0.000239	0.00219	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GCG—pancreatic cancer	0.000238	0.00219	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GCG—pancreatic cancer	0.000238	0.00219	CbGpPWpGaD
Fomepizole—Abdominal pain—Doxorubicin—pancreatic cancer	0.000232	0.000922	CcSEcCtD
Fomepizole—Body temperature increased—Doxorubicin—pancreatic cancer	0.000232	0.000922	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000225	0.00207	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—STK11—pancreatic cancer	0.000224	0.00206	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—STK11—pancreatic cancer	0.000224	0.00206	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CD44—pancreatic cancer	0.000223	0.00206	CbGpPWpGaD
Fomepizole—Diarrhoea—Epirubicin—pancreatic cancer	0.000217	0.000863	CcSEcCtD
Fomepizole—CAT—Metabolism—GCG—pancreatic cancer	0.000214	0.00197	CbGpPWpGaD
Fomepizole—Dizziness—Epirubicin—pancreatic cancer	0.00021	0.000834	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CD44—pancreatic cancer	0.000206	0.00189	CbGpPWpGaD
Fomepizole—Vomiting—Epirubicin—pancreatic cancer	0.000202	0.000802	CcSEcCtD
Fomepizole—CAT—Metabolism—STK11—pancreatic cancer	0.000201	0.00185	CbGpPWpGaD
Fomepizole—Diarrhoea—Doxorubicin—pancreatic cancer	0.000201	0.000798	CcSEcCtD
Fomepizole—Rash—Epirubicin—pancreatic cancer	0.0002	0.000795	CcSEcCtD
Fomepizole—Dermatitis—Epirubicin—pancreatic cancer	0.0002	0.000794	CcSEcCtD
Fomepizole—Headache—Epirubicin—pancreatic cancer	0.000199	0.00079	CcSEcCtD
Fomepizole—ADH1A—Metabolism—GCG—pancreatic cancer	0.000197	0.00181	CbGpPWpGaD
Fomepizole—Dizziness—Doxorubicin—pancreatic cancer	0.000194	0.000771	CcSEcCtD
Fomepizole—ADH1B—Metabolism—TYMS—pancreatic cancer	0.000192	0.00177	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—TYMS—pancreatic cancer	0.000192	0.00177	CbGpPWpGaD
Fomepizole—Nausea—Epirubicin—pancreatic cancer	0.000189	0.000749	CcSEcCtD
Fomepizole—Vomiting—Doxorubicin—pancreatic cancer	0.000187	0.000742	CcSEcCtD
Fomepizole—Rash—Doxorubicin—pancreatic cancer	0.000185	0.000735	CcSEcCtD
Fomepizole—ADH1A—Metabolism—STK11—pancreatic cancer	0.000185	0.0017	CbGpPWpGaD
Fomepizole—Dermatitis—Doxorubicin—pancreatic cancer	0.000185	0.000735	CcSEcCtD
Fomepizole—Headache—Doxorubicin—pancreatic cancer	0.000184	0.000731	CcSEcCtD
Fomepizole—Nausea—Doxorubicin—pancreatic cancer	0.000175	0.000693	CcSEcCtD
Fomepizole—CAT—Metabolism—TYMS—pancreatic cancer	0.000173	0.00159	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—TYMS—pancreatic cancer	0.000159	0.00147	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—APOE—pancreatic cancer	0.000157	0.00144	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—APOE—pancreatic cancer	0.000157	0.00144	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PIK3CG—pancreatic cancer	0.000141	0.0013	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PIK3CG—pancreatic cancer	0.000141	0.0013	CbGpPWpGaD
Fomepizole—CAT—Metabolism—APOE—pancreatic cancer	0.000141	0.0013	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PPARG—pancreatic cancer	0.000136	0.00125	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PPARG—pancreatic cancer	0.000136	0.00125	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—APOE—pancreatic cancer	0.00013	0.00119	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PIK3CG—pancreatic cancer	0.000127	0.00117	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PIK3CD—pancreatic cancer	0.000124	0.00114	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PIK3CD—pancreatic cancer	0.000124	0.00114	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PPARG—pancreatic cancer	0.000123	0.00113	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PIK3CG—pancreatic cancer	0.000117	0.00108	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PPARG—pancreatic cancer	0.000113	0.00104	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PIK3CD—pancreatic cancer	0.000112	0.00103	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PIK3CB—pancreatic cancer	0.000108	0.000995	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PIK3CB—pancreatic cancer	0.000108	0.000995	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTGS2—pancreatic cancer	0.000107	0.000986	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTGS2—pancreatic cancer	0.000107	0.000986	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PIK3CD—pancreatic cancer	0.000103	0.000946	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PIK3CB—pancreatic cancer	9.75e-05	0.000896	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTGS2—pancreatic cancer	9.66e-05	0.000888	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTEN—pancreatic cancer	9.35e-05	0.00086	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTEN—pancreatic cancer	9.35e-05	0.00086	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PRSS1—pancreatic cancer	9.03e-05	0.000831	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PIK3CB—pancreatic cancer	8.97e-05	0.000825	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTGS2—pancreatic cancer	8.89e-05	0.000817	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTEN—pancreatic cancer	8.42e-05	0.000774	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—TGFB1—pancreatic cancer	8.31e-05	0.000764	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ARG2—pancreatic cancer	7.83e-05	0.00072	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTEN—pancreatic cancer	7.75e-05	0.000713	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PRSS1—pancreatic cancer	7.14e-05	0.000656	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—TYMP—pancreatic cancer	6.84e-05	0.000629	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PIK3CA—pancreatic cancer	6.6e-05	0.000607	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PIK3CA—pancreatic cancer	6.6e-05	0.000607	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ARG2—pancreatic cancer	6.19e-05	0.000569	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PIK3CA—pancreatic cancer	5.94e-05	0.000546	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GLP1R—pancreatic cancer	5.52e-05	0.000507	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PIK3CA—pancreatic cancer	5.47e-05	0.000503	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—DPYD—pancreatic cancer	5.43e-05	0.000499	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—TYMP—pancreatic cancer	5.41e-05	0.000497	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—AKT1—pancreatic cancer	5.39e-05	0.000496	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—AKT1—pancreatic cancer	5.39e-05	0.000496	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—SLC2A2—pancreatic cancer	5.15e-05	0.000474	CbGpPWpGaD
Fomepizole—CAT—Metabolism—AKT1—pancreatic cancer	4.85e-05	0.000446	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—AKT1—pancreatic cancer	4.47e-05	0.000411	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GLP1R—pancreatic cancer	4.36e-05	0.000401	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—DPYD—pancreatic cancer	4.29e-05	0.000394	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	4.07e-05	0.000374	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CD44—pancreatic cancer	3.99e-05	0.000367	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GCG—pancreatic cancer	3.82e-05	0.000352	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—STK11—pancreatic cancer	3.6e-05	0.000331	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CD44—pancreatic cancer	3.15e-05	0.00029	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—TYMS—pancreatic cancer	3.09e-05	0.000284	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GCG—pancreatic cancer	3.02e-05	0.000278	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—STK11—pancreatic cancer	2.84e-05	0.000261	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—APOE—pancreatic cancer	2.52e-05	0.000231	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—TYMS—pancreatic cancer	2.44e-05	0.000225	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	2.27e-05	0.000209	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PPARG—pancreatic cancer	2.19e-05	0.000201	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	2e-05	0.000184	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—APOE—pancreatic cancer	1.99e-05	0.000183	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	1.79e-05	0.000165	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	1.74e-05	0.00016	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PPARG—pancreatic cancer	1.73e-05	0.000159	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTGS2—pancreatic cancer	1.72e-05	0.000159	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	1.58e-05	0.000145	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTEN—pancreatic cancer	1.5e-05	0.000138	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	1.37e-05	0.000126	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTGS2—pancreatic cancer	1.36e-05	0.000125	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTEN—pancreatic cancer	1.19e-05	0.000109	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	1.06e-05	9.75e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—AKT1—pancreatic cancer	8.66e-06	7.97e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	8.38e-06	7.71e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—AKT1—pancreatic cancer	6.85e-06	6.3e-05	CbGpPWpGaD
